A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy.

Cortesi, Paolo Angelo; Fornari, Carla; Gisondi, Paolo; Iannone, Florenzo; Antonazzo, Ippazio Cosimo; Aloisi, Elisabetta; Fiocchi, Martina; Ritrovato, Daniela; Mantovani, Lorenzo Giovanni

Cortesi, Paolo Angelo; Fornari, Carla; Gisondi, Paolo; Iannone, Florenzo; Antonazzo, Ippazio Cosimo; Aloisi, Elisabetta; Fiocchi, Martina; Ritrovato, Daniela; Mantovani, Lorenzo Giovanni.

Afiliación

Cortesi PA; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.
Fornari C; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy. carla.fornari@unimib.it.
Gisondi P; Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
Iannone F; DETO, Rheumatology Unit, University of Bari, Policlinico, Bari, Italy.
Antonazzo IC; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.
Aloisi E; Novartis Farma SpA, Origgio, Italy.
Fiocchi M; Novartis Farma SpA, Origgio, Italy.
Ritrovato D; Novartis Farma SpA, Origgio, Italy.
Mantovani LG; Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.

Pharmacoecon Open ; 7(3): 405-416, 2023 May.

Article en En | MEDLINE | ID: mdl-36929647

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Revista: Pharmacoecon Open Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google